Clinical Trials Browser

Head and Neck Squamous Cell Cancer × Cetuximab × Head & Neck × Clear all

NCT03667482 2024-07-23

Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Phase 1 Completed

Head and Neck Squamous Cell Cancer

NCT02282371 2021-10-26

Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)

Phase 1 Completed

Head and Neck Squamous Cell Cancer